Patent Foramen Ovale Repair ProcedureDescription, Latest Information and Doctors
Learn About Patent Foramen Ovale Repair
Konstantinos Tsioufis practices practicing medicine in Athens, Greece. Mr. Tsioufis is rated as an Elite expert by MediFind in Patent Foramen Ovale Repair. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Hypertension, Coronary Heart Disease, Patent Foramen Ovale, Patent Foramen Ovale Repair, and Transcatheter Aortic Valve Replacement (TAVR).
Swedish Cardiac Surgery
Dr. Lehr is a perennial Seattle Met Top Doctor Award winner. Dr. Lehr is rated as an Advanced provider by MediFind in Patent Foramen Ovale Repair. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Aortic Valve Stenosis, Aortic Regurgitation, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery. Dr. Lehr is board certified in Cardiac Surgery. Dr. Lehr is currently accepting new patients.
Atrium Health Sanger Heart & Vascular Institute Surgery Pineville
Larry Watts is a Thoracic Surgeon practicing medicine in Charlotte, North Carolina. Dr. Watts is rated as an Advanced provider by MediFind in Patent Foramen Ovale Repair. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Necrosis, Pleural Effusion, Thoracic Aortic Aneurysm, Heart Bypass Surgery, and Patent Foramen Ovale Repair. Dr. Watts is board certified in American Board Of Surgery and American Board Of Thoracic Surgery. Dr. Watts is currently accepting new patients.
Summary: Patent foramen ovale PFO closure has been shown to reduce the risk of stroke in patients with recurrent stroke. However, the majority of existing clinical studies in this field excluded patients over the age of 60 years. Data in older patients is limited and since the population ages and stroke remains a major cause of death and morbidity, randomized clinical trials are needed to better assess the...
Summary: To determine the safety of antithrombotic treatment discontinuation 12 months following successful transcatheter PFO closure.